Ru Yang

Direttore/Membro del Consiglio presso SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD

40 anni

Technology Services

Consumer Services

Health Services

Profilo

Ru Yang is currently working as an Independent Director at Xiamen Zeesan Biotech Co., Ltd.
and Shenzhen Kingsun Science & Technology Co., Ltd.
Prior to this, Ms. Yang graduated from Southwest University of Political & Law in 2009.

Posizioni attive di Ru Yang

Società	Posizione	Inizio
SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD	Direttore/Membro del Consiglio	01/08/2021
Xiamen Zeesan Biotech Co., Ltd. Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China.	Direttore/Membro del Consiglio	23/08/2021

Tutte le posizioni attive di Ru Yang

Formazione di Ru Yang

Southwest University of Political & Law

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ru Yang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SHENZHEN KINGSUN SCIENCE & TECHNOLOGY CO.,LTD	Technology Services

Aziende private	1
Xiamen Zeesan Biotech Co., Ltd. Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China.	Health Services